Porcilis Begonia DF Suspension for intamuscular injection
Porcilis Begonia DF Suspension for intamuscular injection
Authorised
- Aujeszky's disease virus, strain Begonia gE- tk-, Live
Product identification
Medicine name:
Porcilis Begonia DF Suspension for intamuscular injection
Porcilis Begonia Diluvac
Active substance:
- Aujeszky's disease virus, strain Begonia gE- tk-, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Aujeszky's disease virus, strain Begonia gE- tk-, Live3162280.00tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- (ID12): 1 Box with 10 Box with (1 Bottle (Glass) with 100 Dose and 1 Bottle (Glass) with 200 millilitre(s)) (1000.0 Dose, 2000.0 millilitre(s))
- (ID11): 1 Box with 5 Box with (1 Bottle (Glass) with 100 Dose and 1 Bottle (Glass) with 200 millilitre(s)) (500.0 Dose, 1000.0 millilitre(s))
- (ID10): 1 Box with (1 Bottle (Glass) with 100 Dose and 1 Bottle (Glass) with 200 millilitre(s)) (100.0 Dose, 200.0 millilitre(s))
- (ID9): 1 Box with 10 Box with (1 Bottle (Glass) with 50 Dose and 1 Bottle (Glass) with 100 millilitre(s)) (500.0 Dose, 1000.0 millilitre(s))
- (ID8): 1 Box with 5 Box with (1 Bottle (Glass) with 50 Dose and 1 Bottle (Glass) with 100 millilitre(s)) (250.0 Dose, 500.0 millilitre(s))
- (ID7): 1 Box with (1 Bottle (Glass) with 50 Dose and 1 Bottle (Glass) with 100 millilitre(s)) (50.0 Dose, 100.0 millilitre(s))
- (ID6): 1 Box with 10 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (250.0 Dose, 500.0 millilitre(s))
- (ID5): 1 Box with 5 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (125.0 Dose, 250.0 millilitre(s))
- (ID4): 1 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (25.0 Dose, 50.0 millilitre(s))
- (ID3): 1 Box with 10 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (100.0 Dose, 200.0 millilitre(s))
- (ID2): 1 Box with 5 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (50.0 Dose, 100.0 millilitre(s))
- (ID1): 1 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (10.0 Dose, 20.0 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- PEI
Authorisation number:
- 81a/91
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0012/001
Concerned member states:
-
Belgium
-
France
-
Greece
-
Italy
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 10/02/2022
German (PDF)
Published on: 10/02/2022
How useful was this page?: